Abeona therapeutics inc. (ABEO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-105,886

-76,282

-77,330

-76,377

-64,696

-56,671

-47,642

-36,566

-32,602

-27,319

-25,871

-23,152

-21,576

-21,873

-17,211

-20,660

-18,070

-14,526

-24,129

-19,525

-27,919

-26,778

-15,910

-14,598

-491

4,449

25,351

10,641

-1,559

-10,532

-30,078

-14,861

-5,525

-2,532

0

0

0

Adjustments to reconcile net loss to cash used in operating activities:
Licensed technology impairment charge

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) on change in fair value of derivative-warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

140

36

248

1,236

0

0

0

-

-

-

-

Loss on change in fair value of derivative-preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23,110

-12,271

-11,150

3,813

8,010

29,471

15,150

2,470

-4,770

0

0

0

-

-

-

-

Gain on change in fair value of derivative - warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss on change in fair value of derivative - preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Warrant extension expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,316

2,316

2,316

2,316

0

0

0

0

Depreciation and amortization

8,226

7,819

7,138

5,611

3,844

2,360

1,115

748

665

741

843

927

901

825

727

656

607

551

410

260

129

11

3

3

2

3

330

347

366

419

148

186

226

233

0

0

0

Stock option-based compensation expense

6,491

7,338

6,713

7,386

8,381

8,178

8,189

6,482

5,052

4,644

4,462

4,587

4,729

4,829

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted stock-based compensation expense

1,191

899

520

594

688

688

809

930

1,082

1,272

1,291

1,239

1,902

3,432

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion and interest on short-term investments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of right-of-use lease assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash earnings on investments

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in operating assets and liabilities:
Receivables

-

-81

-337

-7

-26

-26

241

-50

-84

-17

-495

-15

-96

9

335

-218

99

79

267

271

85

-39

-53

-201

-1,172

-766

-425

-529

297

507

362

737

888

-685

0

0

0

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-194

-236

-281

53

43

44

281

97

151

0

0

0

Prepaid expenses and other current assets

-656

-670

-321

406

1,280

1,067

213

1,070

1,629

2,580

1,606

661

262

-160

19

-16

75

287

33

104

16

-77

-13

-202

-160

-174

61

248

199

212

1

-31

-6

-31

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

66

60

29

0

0

0

-

-

-

0

-

-

-

-

-17

-18

-17

15

15

0

0

0

Right-of-use lease assets and other assets

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and lease liabilities

3,723

1,707

2,810

-7,271

-3,239

-7,665

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

124

1,512

421

2,819

945

787

251

-1,174

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock option compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

734

1,305

1,244

1,098

1,157

439

437

496

353

390

606

865

999

1,066

0

0

0

Stock issued to directors, employees and consultants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,852

-2,960

-1,068

-32

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued to directors and employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-167

0

0

0

-

0

0

0

-

-

-

-

Stock issued to directors and employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

401

391

304

361

349

294

221

176

111

132

131

57

77

-45

170

386

602

0

0

0

Contingent consideration milestone

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,591

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

924

35

-1,310

-1,176

-1,400

-864

748

567

760

787

310

53

0

0

0

Interest on dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

592

520

452

358

279

0

0

0

-

0

0

0

-

-

-

-

Dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

0

0

0

Accrued interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-98

-11

-261

-51

-28

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

2,009

-602

-603

-602

-602

-603

-602

-603

-602

-602

-603

-602

-349

-342

-335

3,031

2,866

2,947

3,030

-146

-596

-604

-1,479

-1,606

-1,180

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,021

-9,776

-10,423

-8,648

-6,276

-4,649

-1,611

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-60,974

-62,820

-65,541

-56,327

-50,107

-39,111

-27,190

-24,920

-20,880

-22,655

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,141

-707

-3,219

-3,955

-4,303

-6,818

-7,854

-7,609

0

0

0

Cash flows from investing activities:
Capital expenditures

5,562

6,309

6,850

7,570

6,967

9,243

9,284

7,699

4,288

860

174

250

366

519

768

647

526

308

41

14

9

0

0

0

0

-

-

-

-

13

15

16

31

40

0

0

0

Proceeds from maturities of short-term investments

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of short-term investments

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of short-term investments

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of short-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

400

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-38,669

59,976

63,041

33,383

-58,810

-85,086

-87,909

-77,551

-4,288

-860

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

-15

-16

-31

-40

0

0

0

Cash flows from financing activities:
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-647

3,171

3,389

3,656

3,683

-9

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

969

412

491

587

2,244

2,496

2,425

2,029

344

443

435

350

350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,561

36,052

35,652

48,109

32,948

12,307

12,707

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

113,902

17,374

16,113

3,676

5,477

92,736

94,717

94,231

92,403

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash, cash equivalents and restricted cash

14,231

111,058

14,874

-6,831

-105,241

-118,720

-22,363

-7,754

69,063

68,888

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information:
Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,097

3,893

29,447

28,618

43,117

30,355

7,649

11,096

-734

-1,743

249

28

793

1,210

-1,315

-2,064

-1,242

-3,758

-4,809

-4,573

0

0

0

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

0

0

0

0

58

388

388

388

1,710

720

720

720

0

0

0

Cash paid for interest

-

-

-

-

-

11

10

9

9

8

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares issued for dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

0

0

0

-

-

-

-

Preferred stock dividends in dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,875

2,887

2,889

2,896

2,898

2,878

2,580

2,286

1,999

0

0

0

-

-

-

-

Shares issued for dividends on preferred stock (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

Preferred stock dividends in dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Dollar Five Warrant
Proceeds from exercise of $5.00 warrants

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-